ML13225A251

Dow Chemical Company - Request for Additional Information Regarding the Renewal of Facility Operating License No. R-108 for the Dow Chemical Triga Research Reactor

ML13225A251
Person / Time
Site:	Dow Chemical Company
Issue date:	09/06/2013
From:	Geoffrey Wertz Research and Test Reactors Licensing Branch
To:	O'Connor P Dow Chemical Co
Wertz G, 301-415-0893
References
TAC ME1595
Download: ML13225A251 (6)

Text

September 6, 2013 Paul J. OConnor, Ph.D.

Facility Director Dow Chemical TRIGA Research Reactor Dow Chemical Company Building 1602 Midland, MI 48674

SUBJECT:

DOW CHEMICAL COMPANY - REQUEST FOR ADDITIONAL INFORMATION REGARDING THE RENEWAL OF FACILITY OPERATING LICENSE NO. R-108 FOR THE DOW CHEMICAL TRIGA RESEARCH REACTOR (TAC NO. ME1595)

Dear Dr. OConnor:

The U.S. Nuclear Regulatory Commission (NRC) is continuing its review of your application for the renewal of Facility Operating License No. R-108 for the Dow Chemical TRIGA Research Reactor (DTRR), dated April 1, 2009 (a redacted version of the application is available on the NRCs public Web site at www.nrc.gov under Agencywide Documents Access and Management System (ADAMS) Accession No. ML092150443), as supplemented by letter dated February 7, 2012 (ADAMS Accession No. ML12040A128).

We require additional information and clarification on questions that have arisen during our review. Please provide responses to the enclosed request for additional information within 30 days of the date of this letter. In accordance with Title 10 of the Code of Federal Regulations (10 CFR) Section 50.30(b), you must execute your response in a signed original document under oath or affirmation. Your response must be submitted in accordance with 10 CFR 50.4, Written communications. Information included in your response that is considered sensitive, or proprietary, that you seek to have withheld from the public, must be marked in accordance with 10 CFR 2.390, Public inspections, exemptions, requests for withholding. Information related to security should be submitted in accordance with 10CFR 73.21, Protection of Safeguards Information: Performance requirements.

If you have any questions about this review, or if you need additional time to respond to this request, please contact me at 301-415-0893 or via electronic mail at Geoffrey.Wertz@nrc.gov.

Sincerely,

/Adams Alexander, Jr. for RA/

Geoffrey A. Wertz, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-264 License No. R-108

Enclosure:

Request for Additional Information cc: See next page

Dow Chemical Company Docket No. 50-264 cc:

Office of the Mayor 333 West Ellsworth Midland, MI 48640 Office of the Governor Room 1 - Capitol Building Lansing, MI 48913 Mr. Dan Rader Environmental Health and Safety Responsible Care Leader Chair, Radiation Safety Committee 1790 Building Midland, MI 48674 Dr. Wayde Konze Global Research and Development Director for Analytical Sciences Chair, Reactor Operations Committee The Dow Chemical Company 1897 Building Midland, MI 48667 Test, Research, and Training Reactor Newsletter University of Florida 202 Nuclear Sciences Center Gainesville, FL 32611

ML131225A251

• Concurrence via email NRR-088 OFFICE NRR/DPR/PRLB/LRPM*

NRR/DPR/PRLB/LA NRR/DPR/PROB NRR/DPR/PRLB/BC NRR/DPR/PRLB/LRPM NAME GWertz PBlechman BReed AAdams GWertz (AAdams for)

DATE 08/12/2013 08/13/2013 08/19/2013 09/06/2013 09/06/2013

Enclosure OFFICE OF NUCLEAR REACTOR REGULATION REQUEST FOR ADDITIONAL INFORMATION REGARDING THE RENEWAL REVIEW FOR THE DOW CHEMICAL COMPANY TRIGA RESEARCH REACTOR LICENSE NO. R-108 DOCKET NO. 50-264 The U.S. Nuclear Regulatory Commission (NRC) is continuing its review of your application for the renewal of Facility Operating License No. R-108 for the Dow Chemical TRIGA Research Reactor (DTRR), dated April 1, 2009 (a redacted version of the application is available on the NRCs public Web site at www.nrc.gov under Agencywide Documents Access and Management System (ADAMS) Accession No. ML092150443), as supplemented by letter dated February 7, 2012 (ADAMS Accession No. ML12040A128). We require additional information and clarification on questions that have arisen during our review of the DTRR Physical Security Plan (PSP). Provide responses to the following requests for additional information within 30 days of the date of this letter. Page numbers in brackets [ ] refer to the DTRR Security Plan page.

1. [Page 1] Paragraph 5 describes normal inventory storage. Please describe any non-normal storage characteristics.

2. [Page 1] Discrepancies in the dimensions of the pool, room, and racks were noted between the PSP and Compensatory Measures (CMs). Provide consistent dimensions.

3. [Page 1] Provide clarification on the security status of door 10.

4. [Page 1] Provide Dow Chemical Company documents for any DTRR CM commitments not provided within the DTRR PSP or NRC-approved Emergency Plan.

5. [Page 4] Location of the Dow Chemical Company security dispatcher.

6. [Page 5] Define ITO.

7. [Page 7] Describe the DTRR commitments to the access authorization as cited in Title 10 of the Code of Federal Regulations (10 CFR) 73.57(g), and the site specific CMs. Include the requirements of the reviewing official.

8. [Page 9] Clarify the description of the door with the 6 pin lock.

9. [Page 14] Clarify redundant means of communication.

10. [Page 16] Define normal working hours.

11. The transportation of special nuclear material of low strategic significance is not provided in the DTRR PSP. Describe the process, procedures or actions necessary to meet the requirements of 10 CFR 73.67(g), using information in Regulatory Guide 5.59, Standard Format and Content for a Licensee Physical Security Plan for the Protection of Special Nuclear Material of Moderate or Low Strategic Significance, Revision 1, February 1983 (ADAMS Accession No. ML100341301), to determine the level of detail.